GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Institutional Ownership

Fulgent Genetics (MEX:FLGT) Institutional Ownership : 25.74% (As of Apr. 18, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fulgent Genetics's institutional ownership is 25.74%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fulgent Genetics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fulgent Genetics's Float Percentage Of Total Shares Outstanding is 54.92%.


Fulgent Genetics Institutional Ownership Historical Data

The historical data trend for Fulgent Genetics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Institutional Ownership Chart

Fulgent Genetics Historical Data

The historical data trend for Fulgent Genetics can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 33.80 33.94 34.00 32.98 33.01 33.49 32.40 32.70 32.45 25.74

Fulgent Genetics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Fulgent Genetics Business Description

Traded in Other Exchanges
Address
4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.